ReidWeyantMerrymanMD

Oncology • Boston, MA

Physician

Join to view full profile

Dr. Merryman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Merryman's full profile

Already have an account?

Office
450 Brookline Ave
Boston, MA 02215
Phone+1 617-632-3352

Fax+1 617-632-4422
Is this information wrong?

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2019
Brigham and Women's HospitalResidency, Internal Medicine, 2013 - 2016
Harvard Medical SchoolClass of 2013

Certifications & Licensure

MA State Medical License 2013 - 2026
RI State Medical License 2020 - 2024
NH State Medical License 2024 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL Start of enrollment: 2021 Jun 04
Active, not recruiting
Phase 2
Roles: Contact, Principal Investigator
Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma Start of enrollment: 2023 Jul 18
Recruiting
Phase 2
Roles: Contact, Sponsor-Investigator, Principal Investigator
Zandelisib + Tazemetostat in R/R Follicular Lymphoma Start of enrollment: 2023 Jan 01
Withdrawn
Phase 1, Phase 2
Roles: Principal Investigator, Contact
Epcoritamab and Rituximab for First-line Follicular Lymphoma Start of enrollment: 2023 Jun 21
Recruiting
Phase 2
Roles: Contact, Principal Investigator, Sponsor-Investigator
Join now to see all

Publications & Presentations

PubMed

Advancements in the Management of Follicular Lymphoma: A Comprehensive Review.
Özgür Mehtap, Reid Merryman, Ann LaCasce> ;Turkish Journal of Haematology. 2024 Apr 25
Comparison of whole-genome and immunoglobulin-based circulating tumor DNA assays in diffuse large B-cell lymphoma.
Reid W Merryman, Justin Rhoades, Kan Xiong, Robert A Redd, Katherine Antel, Hyun Hwan An, Mikaela McDonough, Liliana Guerrero, Andela Crnjac, Sainetra Sridhar, Timothy...> ;Hemasphere. 2024 Apr 1
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
Reid W Merryman, Robert A Redd, Arnold S Freedman, Inhye E Ahn, Jennifer R Brown, Jennifer L Crombie, Matthew S Davids, David C Fisher, Eric D Jacobsen, Austin I Kim, ...> ;Annals of Hematology. 2024 Jan 1
3 citations
Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement.
Christine E Ryan, Rebecca L Zon, Robert Redd, David C Fisher, Roni Shouval, Anita Kumar, Jennifer L Crombie, Hossein Sadrzadeh, Austin I Kim, Lakshmi Nayak, Ugonma N C...> ;British Journal of Haematology. 2023 Dec 1
2 citations
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma.
Mwanasha H Merrill, Parastoo B Dahi, Robert A Redd, Mikaela M McDonough, Yi-Bin Chen, Zachariah DeFilipp, Alex F Herrera, David C Fisher, Ann S LaCasce, Oreofe O Odeji...> ;Blood. 2023 Aug 17
Improved survival in cHL with novel agents.
Reid W Merryman, Ann S LaCasce> ;Blood. 2023 Jun 1
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma.
Merryman, R., Michaud, L., Redd, R., Mondello, P., Park, H., Spilberg, G., Robertson, M., Taranto, E., Ahmed, G., Chase, M., Jeter, E., Ahn, I., Brown, J., Crombie, J....> ;Hemasphere. 2023 Feb 1
6 citations
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation.
Reid W Merryman, Robert A Redd, Eleanor Taranto, Gulrayz Ahmed, Erin Jeter, Kristin M McHugh, Jennifer R Brown, Jennifer L Crombie, Matthew S Davids, David C Fisher, A...> ;Blood Advances. 2023 Sep 12
5 citations
Interim FDG-PET/CT for Response Assessment of Lymphoma.
Merissa N Zeman, Esma A Akin, Reid W Merryman, Heather A Jacene> ;Seminars in Nuclear Medicine. 2023 May 1
1 citations
Unresolved questions in the second-line use of CAR-T cells for diffuse large B cell lymphoma.
Edward R Scheffer Cliff, Reid W Merryman, Philippe Armand, Caron A Jacobson> ;Nature Medicine. 2022 Dec 1
1 citations
Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation.
Eleanor Taranto, Robert Redd, Erin Jeter, Kristin McHugh, Jennifer L Crombie, David C Fisher, Eric Jacobsen, Caron A Jacobson, Austin I Kim, Ann S LaCasce, Oreofe O Od...> ;Leukemia & Lymphoma. 2022 Dec 1
16 citations
A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy.
Sushanth Gouni, Allison C Rosenthal, Jennifer L Crombie, Andrew Ip, Manali K Kamdar, Brian Hess, Lei Feng, Grace Watson, Amy Ayers, Sattva S Neelapu, Arushi Khurana, Y...> ;Blood Advances. 2022 May 10
7 citations
Immune reconstitution following high-dose chemotherapy and autologous stem cell transplantation with and without pembrolizumab maintenance therapy in patients with lym...
Reid W. Merryman, Robert A. Redd, Erin Jeter, Jeffrey L. Wong, Kristin M McHugh, Carol Reynolds, Matthew Nazzaro, Aine Varden, Jennifer R. Brown, Jennifer L. Crombie, ...> ;Transplantation and Cellular Therapy. 2021 Oct 17
49 citations
Autologous Transplant versus Chimeric Antigen Receptor T-cell Therapy for Relapsed DLBCL in Partial Remission.
Mazyar Shadman, Marcelo C. Pasquini, Kwang Woo Ahn, Yue Chen, Cameron J. Turtle, Peiman Hematti, Jonathon B. Cohen, Farhad Khimani, Siddhartha Ganguly, Reid W. Merryma...> ;Blood. 2021 Sep 27
7 citations
Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma
Peter A. Riedell, Mehdi Hamadani, Kwang Woo Ahn, Carlos Litovich, Guru Subramanian Guru Murthy, Frederick L. Locke, Claudio G. Brunstein, Reid W. Merryman, Patrick J. ...> ;Transplantation and Cellular Therapy. 2021 Nov 1
22 citations
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma.
Reid W. Merryman, Robert A. Redd, Taiga Nishihori, Julio C. Chavez, Yago Nieto, Justin Darrah, Uttam Rao, Michael Byrne, David A. Bond, Kami J. Maddocks, Michael A. Sp...> ;Blood Advances. 2021 Mar 23
42 citations
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
Reid W. Merryman, Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini, Anna Guidetti, Beatrice Casadei, David A. Bond, Samantha Jaglowski, Michael A. Spinner...> ;Leukemia. 2021 Mar 3
A prospective study of minimal residual disease in patients with diffuse large B-cell lymphoma using an Ig-NGS assay
Matthew L Chase, Reid W. Merryman, David C. Fisher, Eric D. Jacobsen, Ann S. LaCasce, Caron A. Jacobson, Arnold S. Freedman, Matthew S. Davids, Jennifer R. Brown, Alli...> ;Leukemia & Lymphoma. 2021 Jan 28
24 citations
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy.
Nicole A. Carreau, Orrin Pail, Philippe Armand, Reid W. Merryman, Ranjana H. Advani, Michael A. Spinner, Alex F. Herrera, Robert T. Chen, Sarah Tomassetti, Radhakrishn...> ;The Oncologist. 2020 Oct 1
18 citations
Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy
Nicole A. Carreau, Philippe Armand, Reid W. Merryman, Ranjana H. Advani, Michael A. Spinner, Alex F. Herrera, Radhakrishnan Ramchandren, Muhammad Saad Hamid, Sarit Ass...> ;British Journal of Haematology. 2020 Oct 1
3 citations
Total immunotherapy for Hodgkin lymphoma.
Roch Houot, Reid W. Merryman, Franck Morschhauser> ;The Lancet. Haematology. 2020 Sep 1
7 citations
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma
Reid W. Merryman, Nicole A. Carreau, Ranjana H. Advani, Michael A. Spinner, Alex F. Herrera, Robert T. Chen, Sarah Tomassetti, Radhakrishnan Ramchandren, Muhammad Hami...> ;The Oncologist. 2020 Jun 1
4 citations
Immune and Cell Therapy in Non-Hodgkin Lymphoma
Reid W. Merryman, Roch Houot, Philippe Armand, Caron A. Jacobson> ;Cancer Journal. 2020 May 1
33 citations
Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma.
Reid W. Merryman, Natasha Catherine Edwin, Robert A. Redd, Jad Bsat, Matthew L Chase, Ann S. LaCasce, Arnold S. Freedman, Caron A. Jacobson, David C. Fisher, Samuel Ng...> ;Blood Advances. 2020 Mar 10
3 citations
Novel agents and immune invasion in Hodgkin lymphoma.
Reid W. Merryman, Ann S. LaCasce> ;Hematology. American Society of Hematology. Education Program. 2019 Dec 6
Join now to see all

Abstracts/Posters

Preliminary Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Le...
Reid W Merryman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin Lymphoma
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

BEGEV Salvage Regimen Linked to High Complete Remission RatesFebruary 18th, 2020
Treatment with PD-1 Prior to Stem Cell Transplant Is Safe for Hodgkin Lymphoma PatientsDecember 9th, 2019
ASCO 2023: Lymphoma Research Could Change PracticeJune 28th, 2023